NATALIA GARCÍA SANCHA-rekin lankidetzan egindako argitalpenak (13)

2024

  1. A susceptibility gene signature for ERBB2-driven mammary tumour development and metastasis in collaborative cross mice

    eBioMedicine, Vol. 106

  2. NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence

    Clinical and Translational Medicine, Vol. 14, Núm. 2

2023

  1. Cutaneous squamous cell carcinoma: From biology to therapy

    Advances in Surgical and Medical Specialties (Taylor and Francis), pp. 393-424

  2. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

  3. TMeB score may improve risk stratification of high-risk cutaneous squamous cell carcinoma and guide management of patients: A pilot study

    Journal of the European Academy of Dermatology and Venereology

2022

  1. Evolutionary Origins of Metabolic Reprogramming in Cancer

    International journal of molecular sciences, Vol. 23, Núm. 20

  2. From Mouse to Human: Cellular Morphometric Subtype Learned From Mouse Mammary Tumors Provides Prognostic Value in Human Breast Cancer

    Frontiers in Oncology, Vol. 11

  3. Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer

    Cancers, Vol. 14, Núm. 2

2021

  1. Overcoming resistance to immunotherapy in advanced cutaneous squamous cell carcinoma

    Cancers, Vol. 13, Núm. 20

  2. Viruses and skin cancer

    International Journal of Molecular Sciences, Vol. 22, Núm. 10

2020

  1. Cutaneous squamous cell carcinoma: From biology to therapy

    International Journal of Molecular Sciences, Vol. 21, Núm. 8

  2. Stromal SNAI2 is required for ERBB2 breast cancer progression

    Cancer Research, Vol. 80, Núm. 23, pp. 5216-5230

2019

  1. MicroRNA dysregulation in cutaneous squamous cell carcinoma

    International Journal of Molecular Sciences, Vol. 20, Núm. 9